- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04820725
The Effects of Postural Changes on Plantar Pressure in Patients With Ankylosing Spondylitis
March 25, 2021 updated by: Songul Baglan Yentur, Gazi University
Ankylosing Spondlitis (AS) is a chronic, rheumatic disease.
Foot and ankle involvement may stem from both postural changes in patients seen spinal deformity with the progress of the disease and enthesitis.
The purpose of the study is to investigate the relationship plantar pressure distribution and balance, mobility and disease activity in AS patients and to compare AS patients with and without postural changes and healthy subjects.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Ankylosing Spondlitis (AS) is a chronic, rheumatic disease.
Reduction in flexibility and mobility is important factors that can cause impairment quality of life, reduction of exercise tolerance and pulmonary capacity with the progression of AS.
Extra articular symptoms such as neurologic, cardiovascular and pulmonary involvement affect morbidity and mortality rate.
Foot and ankle involvement may stem from both postural changes in patients seen spinal deformity with the progress of the disease and enthesitis.
Şahlı et al. concluded that 52% of AS patients had foot involvement but 35% of the patients had symptoms.
To be determined plantar pressure distribution is important to be decided body weight distribution, postural control and selection of shoes.
The purpose of the study is to investigate the relationship plantar pressure distribution and balance, mobility and disease activity in AS patients and to compare AS patients with and without postural changes and healthy subjects.
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Songul B Yentur
- Phone Number: 0424 237 8282
- Email: songulbaglan23@hotmail.com
Study Locations
-
-
-
Elazığ, Turkey, 23000
- Recruiting
- Songül Bağlan Yentür
-
Contact:
- Songul B Yentur
- Phone Number: +90 506 272 6511
- Email: songulbaglan23@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients who are aged between 18-55 years,
- Patients who got diagnosed according to Modified New York criteria
- Patients who are being followed at Firat University Department of Rheumatology.
Exclusion Criteria:
- Patients who have exercise habits
- Incooperation
- Malignancy
- Pregnancy
- Patients who have changes of medical treatment in the last 3 months
- Patients who have another disease that can effect pulmonary functions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study group
Patients whose BASMI score is 2 will be included in the study
|
Gait analyses (cadence, stride length, swing phase duration, step duration and double stand duration) will be evaluated using Win-Track platform (MEDICAPTEURS Technology, France).
|
Experimental: Control group
Patients whose BASMI score is 0 and 1 will be included in the study
|
Gait analyses (cadence, stride length, swing phase duration, step duration and double stand duration) will be evaluated using Win-Track platform (MEDICAPTEURS Technology, France).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gait analyses
Time Frame: 3 minutes
|
plantar pressure distribution
|
3 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bath Ankylosing Spondylitis Metrology Index
Time Frame: 5 minutes
|
Spinal mobility will assessed and scored by Bath Ankylosing Spondylitis Metrology Index (BASMI).
There are five measurements including lateral lumbar flexion, tragus-to-wall distance, lumbar flexion (Modified Schober), maximal intermalleolar distance and cervical rotation according to the index.
Each subscale is scored between 0 and 10.
All points are then averaged to calculate total score.
Higher values represent worse outcomes.
|
5 minutes
|
Bath Ankylosing Spondylitis Disease Activity Index
Time Frame: 1 minute
|
Bath Ankylosing Spondylitis Disease Activity Index which consists of 6 questions will be used to evaluate disease activity.
BASDAI is a composite index, consisting of an assessment on a 10 cm horizontal visual analog scale of fatigue, axial pain, peripheral pain, enthesopathy and stiffness.
Fifth and sixth questions are averaged.
Addition to this score, other questions are averaged.
Total score is between 0 and 10.
Higher score represent worse outcome.
|
1 minute
|
Time up and go test
Time Frame: 1 minute
|
The patient starts in a seated position.
The patient stands up upon therapist's command: walks 3 meters, turns around, walks back to the chair and sits down.
The time stops when the patient is seated.
|
1 minute
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Süleyman S Koca, Firat University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Sahli H, Bachali A, Tekaya R, Mahmoud I, Sedki Y, Saidane O, Abdelmoula L. Involvement of foot in patients with spondyloarthritis: Prevalence and clinical features. Foot Ankle Surg. 2019 Apr;25(2):226-230. doi: 10.1016/j.fas.2017.10.016. Epub 2017 Nov 10.
- Aydin E, Turan Y, Tastaban E, Kurt Omurlu I, Sendur OF. Plantar pressure distribution in patients with ankylosing spondylitis. Clin Biomech (Bristol, Avon). 2015 Mar;30(3):238-42. doi: 10.1016/j.clinbiomech.2015.02.003. Epub 2015 Feb 8.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
October 31, 2021
Primary Completion (Anticipated)
August 17, 2022
Study Completion (Anticipated)
December 2, 2022
Study Registration Dates
First Submitted
March 25, 2021
First Submitted That Met QC Criteria
March 25, 2021
First Posted (Actual)
March 29, 2021
Study Record Updates
Last Update Posted (Actual)
March 29, 2021
Last Update Submitted That Met QC Criteria
March 25, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 05-06
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ankylosing Spondylitis
-
Shanghai Junshi Bioscience Co., Ltd.Sponsor GmbHRecruitingActive Ankylosing SpondylitisChina
-
AbbVieBoehringer IngelheimCompletedAnkylosing Spondylitis (AS)
-
Sun Yat-sen UniversityUnknownEarly Ankylosing Spondylitis
-
AbbVieCompletedAnkylosing Spondylitis (AS)United States, Australia, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Spain, Sweden, United Kingdom
-
AbbVieCompletedAnkylosing Spondylitis (AS)Taiwan
-
Tongji HospitalWuhan Central Hospital; Wuhan Hospital of Traditional Chinese MedicineRecruitingAnkylosing Spondylitis (AS)China
-
Chinese University of Hong KongCompletedAnkylosing Spondylitis(AS)China
-
Tianjin Hemay Pharmaceutical Co., LtdCompletedActive Ankylosing SpondylitisChina
-
Jiangsu vcare pharmaceutical technology co., LTDRecruitingActive Ankylosing SpondylitisChina
-
Ankara City Hospital BilkentRecruitingAxial Spondyloarthritis and Ankylosing SpondylitisTurkey
Clinical Trials on Plantar pressure and gait
-
Universitaire Ziekenhuizen KU LeuvenRecruitingAnkle and Hindfoot AlterationsBelgium
-
Emory UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
Istituto Ortopedico RizzoliRecruitingPlantar PressureItaly
-
Baskent UniversityCompleted
-
Amasya UniversityCompletedDevice is Used for Evalution (Event)
-
Istanbul Medipol University HospitalCompletedTemporomandibular DisorderTurkey
-
Sultan Abdulhamid Han Training and Research Hospital...CompletedPelvic Girdle Pain | Pregnant Woman | Biomechanical and Viscoelastic Properties of Plantar FasciaTurkey
-
Acibadem UniversityCompletedPes Planus | Morton Neuroma | Pes CavusTurkey
-
St George's, University of LondonImperial College LondonUnknownPatellar DislocationUnited Kingdom
-
Centre Hospitalier Universitaire DijonRecruitingBone Reconstruction by Free Fibula FlapFrance